Axid is a brand name of nizatidine, approved by the FDA in the following formulation(s):
AXID (nizatidine - capsule; oral)
Manufacturer: SMITHKLINE BEECHAM
Approval date: April 12, 1988
Strength(s): 150MG [AB], 300MG [RLD][AB]
AXID (nizatidine - solution; oral)
Manufacturer: BRAINTREE
Approval date: May 25, 2004
Strength(s): 15MG/ML [RLD][AA]
Has a generic version of Axid been approved?
A generic version of Axid has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Axid and have been approved by the FDA:
nizatidine capsule; oral
Manufacturer: APOTEX
Approval date: January 23, 2003
Strength(s): 150MG [AB], 300MG [AB]
Manufacturer: DR REDDYS LABS LTD
Approval date: September 15, 2005
Strength(s): 150MG [AB], 300MG [AB]
Manufacturer: GLENMARK GENERICS
Approval date: July 15, 2011
Strength(s): 150MG [AB], 300MG [AB]
Manufacturer: MYLAN
Approval date: July 5, 2002
Strength(s): 150MG [AB], 300MG [AB]
Manufacturer: MYLAN
Approval date: July 9, 2002
Strength(s): 150MG [AB], 300MG [AB]
Manufacturer: SANDOZ
Approval date: July 5, 2002
Strength(s): 150MG [AB], 300MG [AB]
Manufacturer: TEVA
Approval date: September 12, 2002
Strength(s): 150MG [AB], 300MG [AB]
Manufacturer: WATSON LABS
Approval date: July 9, 2002
Strength(s): 150MG [AB], 300MG [AB]
nizatidine solution; oral
Manufacturer: AMNEAL PHARMS
Approval date: November 18, 2009
Strength(s): 15MG/ML [AA]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Axid. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Liquid pharmaceutical composition
Patent 6,930,119
Issued: August 16, 2005
Inventor(s): Bobotas; George & Fawzy; Abdel A.
Assignee(s): Reliant Pharmaceuticals, Inc.
This invention relates to new pharmaceutical compositions and methods for their preparation, and in particular it relates to taste-masked liquid compositions comprising a solution of a histamine H2-antagonist complexed with an alginate and also containing a humectant. The solution is buffered to a pH of between about 6 to 7. The inventive solution may be flavored and sweetened and preserved.Patent expiration dates:
- July 17, 2022✓
- July 17, 2022
See also...
- Axid Consumer Information (Drugs.com)
- Axid Consumer Information (Wolters Kluwer)
- Axid Solution Consumer Information (Wolters Kluwer)
- Axid Consumer Information (Cerner Multum)
- Axid AHFS DI Monographs (ASHP)
- Nizatidine Consumer Information (Wolters Kluwer)
- Nizatidine Solution Consumer Information (Wolters Kluwer)
- Nizatidine Consumer Information (Cerner Multum)
- Nizatidine AHFS DI Monographs (ASHP)
No comments:
Post a Comment